Literature DB >> 19294600

Biotin-responsive basal ganglia disease: case report and review of the literature.

T I El-Hajj1, P E Karam, M A Mikati.   

Abstract

Biotin-responsive basal ganglia disease is a rare entity of which 10 cases have been reported in the literature. We report a case of biotin-responsive basal ganglia disease with similarities and differences compared to the previously reported cases by Ozand et al. Our case presented much earlier, was milder and responded better to lower doses of biotin, compared to the cases reported previously. Since our case showed differences with those in the literature, it might represent a new entity or a milder form of the same entity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294600     DOI: 10.1055/s-0028-1128152

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  7 in total

1.  Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment.

Authors:  H Kassem; A Wafaie; S Alsuhibani; T Farid
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

2.  Biotin-Thiamine Responsive Encephalopathy: Report of an Egyptian Family with a Novel SLC19A3 Mutation and Review of the Literature.

Authors:  Salvatore Savasta; Francesco Bassanese; Chiara Buschini; Thomas Foiadelli; Chiara Trabatti; Stephanie Efthymiou; Vincenzo Salpietro; Henry Houlden; Annamaria Simoncelli; Gian Luigi Marseglia
Journal:  J Pediatr Genet       Date:  2018-12-18

Review 3.  Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases.

Authors:  Majid Alfadhel; Makki Almuntashri; Raafat H Jadah; Fahad A Bashiri; Muhammad Talal Al Rifai; Hisham Al Shalaan; Mohammed Al Balwi; Ahmed Al Rumayan; Wafaa Eyaid; Waleed Al-Twaijri
Journal:  Orphanet J Rare Dis       Date:  2013-06-06       Impact factor: 4.123

4.  Early treatment of biotin-thiamine-responsive basal ganglia disease improves the prognosis.

Authors:  Dorota Wesół-Kucharska; Milena Greczan; Magdalena Kaczor; Magdalena Pajdowska; Dorota Piekutowska-Abramczuk; Elżbieta Ciara; Paulina Halat-Wolska; Paweł Kowalski; Elżbieta Jurkiewicz; Dariusz Rokicki
Journal:  Mol Genet Metab Rep       Date:  2021-09-29

Review 5.  On the dynamic and even reversible nature of Leigh syndrome: Lessons from human imaging and mouse models.

Authors:  Melissa A Walker; Maria Miranda; Amanda Allred; Vamsi K Mootha
Journal:  Curr Opin Neurobiol       Date:  2021-10-14       Impact factor: 7.070

Review 6.  Report of the Largest Chinese Cohort With SLC19A3 Gene Defect and Literature Review.

Authors:  Jiaping Wang; Junling Wang; Xiaodi Han; Zhimei Liu; Yanli Ma; Guohong Chen; Haoya Zhang; Dan Sun; Ruifeng Xu; Yi Liu; Yuqin Zhang; Yongxin Wen; Xinhua Bao; Qian Chen; Fang Fang
Journal:  Front Genet       Date:  2021-07-01       Impact factor: 4.599

Review 7.  Drug treatment of inborn errors of metabolism: a systematic review.

Authors:  Majid Alfadhel; Khalid Al-Thihli; Hiba Moubayed; Wafaa Eyaid; Majed Al-Jeraisy
Journal:  Arch Dis Child       Date:  2013-03-26       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.